Article Details

Audentes CEO exits as Astellas rebrands a gene therapy buyout

Retrieved on: 2021-04-01 13:43:27

Tags for this article:

Click the tags to see associated articles and topics

Audentes CEO exits as Astellas rebrands a gene therapy buyout. View article details on hiswai:

Excerpt

... but Holles and "some members" of the Audentes leadership team will not transition over, an Astellas spokesperson confirmed to BioPharma Dive.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up